Code | 2009E | ||||||||||
MA number | 44/0245/22-S | ||||||||||
Product Form: | plo ijf 1x1 000 mg (liek.inj.skl.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 01.10.2022 |
Validity: | 01.10.2027 |
Pediatric posology: | Yes |
PIL: | PIL_Cyklofosfamid Accord prášok na injekčný_infúzny roztok_09_2022.pdf |
SPC: | SPC_Cyklofosfamid Accord prášok na injekčný_infúzny roztok_09_2022.pdf |
Safety feature | Yes |
Data update: | 03.10.2022 |